Announcements

Paul G. Allen Frontiers Group [to 18 July 2020]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
No new digest content identified.

BARDA – U.S. Department of HHS [to 18 July 2020]
https://www.phe.gov/about/barda/Pages/default.aspx
BARDA News
No new digest content identified.

BMGF – Gates Foundation [to 18 July 2020]
http://www.gatesfoundation.org/Media-Center/Press-Releases
No new digest content identified.

Bill & Melinda Gates Medical Research Institute [to 18 July 2020]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
NEJM
Editorial
The Covid-19 Vaccine-Development Multiverse
Penny M. Heaton, M.D.
[See Milestones above for detail]

CARB-X [to 18 July 2020]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.

CEPI – Coalition for Epidemic Preparedness Innovations [to 18 July 2020]
http://cepi.net/
Latest News
More than 150 countries engaged in COVID-19 Vaccine Global Access Facility
Interest from governments represents more than 60% of the world’s population.
COVID-19
15 Jul 2020
[See Milestones above for detail]

University of Queensland vaccine becomes seventh CEPI-supported COVID-19 vaccine candidate to enter clinical trials
The first participants were today enrolled into a Phase 1 clinical trial of the University of Queensland’s candidate vaccine.
Blog
13 Jul 2020

EDCTP [to 18 July 2020]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
No new digest content identified.

Emory Vaccine Center [to 18 July 2020]
http://www.vaccines.emory.edu/
Vaccine Center News
mRNA Vaccine Against SARS-CoV-2 Preliminary Report

European Medicines Agency [to 18 July 2020]
http://www.ema.europa.eu/ema/
News & Press Releases 
No new digest content identified.

European Vaccine Initiative [to 18 July 2020]
http://www.euvaccine.eu/
Latest News
No new digest content identified.

FDA [to 18 July 2020]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements
July 18, 2020 – Coronavirus (COVID-19) Update: FDA Issues First Emergency Authorization for Sample Pooling in Diagnostic Testing

July 17, 2020 – Coronavirus (COVID-19) Update: Daily Roundup July 17, 2020

July 16, 2020 – Coronavirus (COVID-19) Update: Daily Roundup July 16, 2020

July 15, 2020 – Coronavirus (COVID-19) Update: Daily Roundup July 15, 2020

July 14, 2020 – Coronavirus (COVID-19) Update: Daily Roundup July 14, 2020

July 13, 2020 – Coronavirus (COVID-19) Update: Daily Roundup July 13, 2020

Fondation Merieux [to 18 July 2020]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.

Gavi [to 18 July 2020]
https://www.gavi.org/
News releases
15 July 2020
More than 150 countries engaged in COVID-19 vaccine global access facility
[See Milestones above detail]

GHIT Fund [to 18 July 2020]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.

Global Fund [to 18 July 2020]
https://www.theglobalfund.org/en/news/
No new digest content identified.

Hilleman Laboratories [to 18 July 2020]
http://www.hillemanlabs.org/
No new digest content identified.

Human Vaccines Project [to 18 July 2020]
http://www.humanvaccinesproject.org/media/press-releases/
No new digest content identified.

IAVI [to 18 July 2020]
https://www.iavi.org/newsroom
No new digest content identified.

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

IFFIm
http://www.iffim.org/
Announcements
No new digest content identified.

IFRC [to 18 July 2020]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
Asia Pacific, Bangladesh, India, Pakistan
Red Cross Red Crescent braces for COVID spike in South Asia
Kuala Lumpur/Delhi/Islamabad/Dhaka/Geneva, 16 July 2020 – South Asia is fast becoming the next COVID-19 epicentre as cases soar in India, Pakistan and Bangladesh. John Fleming, Asia Pacific Head of Health, International Federation of Red Cross and Red …
16 July 2020

Afghanistan, Asia Pacific
Race to avert COVID-19 caused catastrophes in Afghanistan
Kabul/Kuala Lumpur/Geneva, 14 July 2020: Afghanistan is on the edge of potential health, social and economic catastrophes caused by COVID-19 as the disease places a crippling burden on one of the ten most fragile states in the world. More than 34,000 p …
14 July 2020

IVAC [to 18 July 2020]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates
Webinar: Responding to the Impact of COVID-19 on Refugees
July 2020
Register: The International Vaccine Access Center (IVAC) on July 29, 2020 at 1pm ET will host a 60-minute webinar, “Responding to the Impact of COVID-19 on Refugees.”
Description: The concern for refugee populations and their risk to preventable diseases during the COVID-19 pandemic is high. Refugee camps are home to concentrated groups of people with limited access to health services – making the spread of disease easy but the delivery of treatments difficult. Existing vaccines offer vulnerable populations a critical piece of preventative medicine, especially to children who suffer most during a humanitarian crisis. Disease modeling and humanitarian health experts at JHU will discuss what impact COVID-19 will have in terms of infections and outcomes in refugee camps, and the response needed to protect children with routine immunizations and a potential COVID-19 vaccine.
Register Here

IVI [to 18 July 2020]
http://www.ivi.int/
Selected IVI News & Announcements
No new digest content identified.

JEE Alliance [to 18 July 2020]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

MSF/Médecins Sans Frontières [to 18 July 2020]
http://www.msf.org/
Latest [Selected Announcements]
Philippines
Displaced communities in Marawi living with COVID-19 and ongoing un…
Project Update 17 Jul 2020

Belgium
Left behind in the time of COVID-19
Report 17 Jul 2020

Burkina Faso
Displaced in Burkina Faso face extra challenges amid increasing violence and rain
Project Update 16 Jul 2020

Greece
Greek government must end lockdown for locked up people on Greek islands
Project Update 16 Jul 2020

Iraq
Displaced people are extremely vulnerable to COVID-19 in Iraq
Press Release 14 Jul 2020

Greece
Vulnerable refugees evicted and left to sleep on streets
Press Release 13 Jul 2020

National Vaccine Program Office – U.S. HHS [to 18 July 2020]
https://www.hhs.gov/vaccines/about/index.html
NVAC 2020 Meetings
September 23-24, 2020 Meeting (Virtual)

NIH [to 18 July 2020]
http://www.nih.gov/news-events/news-releases
Selected News Releases
Experimental COVID-19 vaccine safe, generates immune response
July 14, 2020 — NIH-sponsored Phase 1 trial tested mRNA vaccine.
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online today in The New England Journal of Medicine….

Placenta lacks major molecules used by SARS-CoV-2 virus to cause infection
July 14, 2020 — NIH study may help explain why the virus has rarely been found in fetuses or newborns of women with COVID-19.

PATH [to 18 July 2020]
https://www.path.org/media-center/
Selected Announcements
No new digest content identified.

Sabin Vaccine Institute [to 18 July 2020]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
Sabin’s President of Global Immunization Dr. Bruce Gellin Testifies at House Briefing on Approval Processes for Safe, Effective COVID-19 Vaccine
Bruce Gellin, M.D., M.P.H., president of Global Immunization at the Sabin Vaccine Institute (Sabin) and former Deputy Assistant Secretary for Health and Director of the National Vaccine Program Office at the U.S. Department of Health and Human Services (HHS), testified on July, 14, 2020, at the House Subcommittee on Economic and Consumer Policy’s briefing entitled “Guardrails to Ensure a Safe and Effective COVID-19 Vaccine.”

UNAIDS [to 18 July 2020]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
17 July 2020
Fostering an economy of kindness through traditional bartering in Fiji

14 July 2020
Delivering antiretroviral medicines to homes in Côte d’Ivoire and Nigeria

UNICEF [to 18 July 2020]
https://www.unicef.org/media/press-releases
Selected Press releases/Announcements
Press release
07/15/2020
WHO and UNICEF warn of a decline in vaccinations during COVID-19
WHO and UNICEF call for immediate efforts to vaccinate all children as new data shows that, before the COVID-19 pandemic, vaccine coverage stalled at 85 per cent for nearly a decade, with 14 million unvaccinated infants yearly

Press release
07/13/2020
As more go hungry and malnutrition persists, achieving Zero Hunger by 2030 in doubt, UN report warns
Securing healthy diets for the billions who cannot afford them would save trillions in costs

Unitaid [to 18 July 2020]
https://unitaid.org/
Featured News
No new digest content identified.

Vaccination Acceptance Research Network (VARN) [to 18 July 2020]
https://vaccineacceptance.org/news.html#header1-2r
Announcements
No new digest content identified.

Vaccine Confidence Project [to 18 July 2020]
http://www.vaccineconfidence.org/
Latest News & Archive
Event: Vaccine confidence in the time of COVID-19
The VCP will be launching a new Lancet publication analysing 5 years of global vaccine confidence trends & discussing the implications for new COVID-19 vaccines
22nd July, 2-3.30pm (BST)
This webinar will mark the launch of a five-year analysis of vaccine confidence data to be published in the Lancet on July 21st (23:30 BST embargo). “Spatio-temporal trends in vaccine confidence: a global analysis exploring volatility, polarization, and trust.” is a valuable mapping of the current global vaccine confidence landscape and trends. This webinar will present the key findings and highlights from the study and discuss the implications for the introduction of potential COVID-19 vaccines.
Register here.

Vaccine Education Center – Children’s Hospital of Philadelphia [to 18 July 2020]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.

Wellcome Trust [to 18 July 2020]
https://wellcome.ac.uk/news
Opinion | 14 July 2020
How could COVID-19 change research culture for the better?
Ben Bleasdale
Senior Policy Adviser Wellcome
COVID-19 is transforming every aspect of society – and research is no exception. But how can we use what we’ve learned in the past six months to build a better research culture?

The Wistar Institute [to 18 July 2020]
https://www.wistar.org/news/press-releases
Press Released
No new digest content identified.

WFPHA: World Federation of Public Health Associations [to 18 July 2020]
https://www.wfpha.org/
Latest News
No new digest content identified.

World Organisation for Animal Health (OIE) [to 18 July 2020]
https://www.oie.int/en/for-the-media/press-releases/2020/
Press Releases
No new digest content identified.

::::::

ARM [Alliance for Regenerative Medicine] [to 18 July 2020]
https://alliancerm.org/press-releases/
Press Releases
No new digest content identified.

BIO [to 18 July 2020]
https://www.bio.org/press-releases
Press Releases
BIO CEO Defends Dr. Fauci, Says Criticisms “Undermine Our Response to this Pandemic”
July 16, 2020
In response to attacks on Dr. Anthony Fauci’s credibility and character, BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement: “As this global pandemic continues to wreak havoc, we must stand behind the scientists and…

DCVMN – Developing Country Vaccine Manufacturers Network [to 18 July 2020]
http://www.dcvmn.org/
News; Upcoming events
WEBINAR: Defining the concept on fair pricing for medicines
21 July 2020

IFPMA [to 18 July 2020]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
No new digest content identified.

ICBA – International Council of Biotechnology Associations [to 18 July 2020]
https://internationalbiotech.org/
News
No new digest content identified.

PhRMA [to 18 July 2020]
http://www.phrma.org/
Selected Press Releases, Statements
R&D Focus: 5 things to know about the biopharmaceutical research ecosystem
Jocelyn Ulrich   |     July 13, 2020  |
America’s biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that develops more innovative medicines than any other country in the world. In recent years, rapid advances in scientific discovery have ushered in a new era of medicine, transforming our ability to treat, and in some cases cure, some of the most challenging diseases, including cancer, rare diseases and autoimmune conditions. These advancements are due to the productivity of the United States’ biomedical research ecosystem, which is sustained by a policy framework that is designed to support and advance America’s leadership in the innovation of new medicines.

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

Annals of Internal Medicine
7 July 2020 Volume 173, Issue 1
http://annals.org/aim/issue

Latest
16 July 2020
Original Research
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
Caleb P. Skipper, MD, et al
There is no known effective oral therapy for early COVID-19. This randomized, double-blind, placebo-controlled trial evaluated effects of oral hydroxychloroquine on symptoms and disease severity in adult outpatients with early COVID-19.

Annals of Internal Medicine
7 July 2020 Volume 173, Issue 1
http://annals.org/aim/issue

Editorials
The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale
Neil W. Schluger, MD
In their article, Skipper and colleagues report the results of trial of hydroxychloroquine for patients presenting with nonsevere COVID-19. The editorialists discuss the findings and the need to examine carefully not only what we know about hydroxychloroquine and COVID-19 but also how we learned it, disseminated it, and put it into practice.

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 18 July 2020)

Rotavirus group A genotype circulation patterns across Kenya before and after nationwide vaccine introduction, 2010–2018
Kenya introduced the monovalent G1P [8] Rotarix® vaccine into the infant immunization schedule in July 2014. We examined trends in rotavirus group A (RVA) genotype distribution pre- (January 2010–June 2014) an…
Authors: Mike J. Mwanga, Betty E. Owor, John B. Ochieng, Mwanajuma H. Ngama, Billy Ogwel, Clayton Onyango, Jane Juma, Regina Njeru, Elijah Gicheru, Grieven P. Otieno, Sammy Khagayi, Charles N. Agoti, Godfrey M. Bigogo, Richard Omore, O. Yaw Addo, Seheri Mapaseka…
Citation: BMC Infectious Diseases 2020 20:504
Content type: Research article
Published on: 13 July 2020

BMC Medicine
http://www.biomedcentral.com/bmcmed/content
(Accessed 18 July 2020)

Systems and implementation science should be part of the COVID-19 response in low resource settings
Authors: Mike English, Mosa Moshabela, Jacinta Nzinga, Edwine Barasa, Benjamin Tsofa, Bruno Marchal and Margaret E Kruk
Citation: BMC Medicine 2020 18:219
Content type: Commentary
Published on: 15 July 2020

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 18 July 2020)

The role of the Stop Transmission of Polio (STOP) program in developing countries: the experience of Kenya
In 1988, the 41st World Health Assembly (WHA) marked the launch of the Global Polio Eradication Initiative (GPEI) for the eradication of polio. A key component of the GPEI has been the development and deployment …
Authors: Brook Tesfaye, Jeevan K. Makam, Kibet Sergon, Iheoma Onuekwusi, Charles Muitherero and Alieu Sowe
Citation: BMC Public Health 2020 20:1110
Content type: Research article
Published on: 14 July 2020

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 18 July 2020)

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
Meningococcal serogroup B (MenB) is the most common cause of invasive meningococcal disease (IMD) in the United States. The US Advisory Committee on Immunization Practices (ACIP) recommends vaccination of heal…
Authors: Amit Srivastava, Amanda Dempsey, Alex Galitsky, Mansour Fahimi and Liping Huang
Citation: BMC Public Health 2020 20:1109
Content type: Research article
Published on: 14 July 2020

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 18 July 2020)

Barriers to childhood immunization in sub-Saharan Africa: A systematic review
Immunization to prevent infectious diseases is a core strategy to improve childhood health as well as survival. It remains a challenge for some African countries to attain the required childhood immunization c…
Authors: Joseph Benjamin Bangura, Shuiyuan Xiao, Dan Qiu, Feiyun Ouyang and Lei Chen
Citation: BMC Public Health 2020 20:1108
Content type: Research article
Published on: 14 July 2020

Clinical Pharmacology & Therapeutics
Volume 108, Issue 1 Pages: 1-161 July 2020
https://ascpt.onlinelibrary.wiley.com/toc/15326535/2020/108/1

Editorial Free Access
COVID‐19: A Defining Moment for Clinical Pharmacology?
Piet H. van der Graaf, Kathleen M. Giacomini
Pages: 11-15
First Published:29 April 2020

Ethics & Human Research
Volume 42, Issue 4 Pages: 1-40 July–August 2020
https://onlinelibrary.wiley.com/toc/25782363/current

Pregnant Women Covid‐19 Vaccine Challenge Trials Lotteries
Articles
The Pathway Forward: Insights on Factors that Facilitate Research with Pregnant Women
Anna C. Mastroianni, Robert Franceschini, Sarah L. Wicks, Leslie Meltzer Henry
Pages: 2-16
First Published: 16 July 2020

Ethics & Human Research
Volume 42, Issue 4 Pages: 1-40 July–August 2020
https://onlinelibrary.wiley.com/toc/25782363/current

Articles
Free Access
Pregnant Women in Trials of Covid‐19: A Critical Time to Consider Ethical Frameworks of Inclusion in Clinical Trials
Ruth Farrell, Marsha Michie, Rachel Pope
Pages: 17-23
First Published: 20 June 2020

Ethics & Human Research
Volume 42, Issue 4 Pages: 1-40 July–August 2020
https://onlinelibrary.wiley.com/toc/25782363/current

Why Challenge Trials of SARS‐CoV‐2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events
Nir Eyal

Pages: 24-34
First Published: 22 May 2020

Ethics & Human Research
Volume 42, Issue 4 Pages: 1-40 July–August 2020
https://onlinelibrary.wiley.com/toc/25782363/current

Advantages of Using Lotteries to Select Participants for High‐Demand Covid‐19 Treatment Trials
Alexander A. Iyer, Saskia Hendriks, Annette Rid

Pages: 35-40
First Published: 22 June 2020

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 18 July 2020]

Open Letter metrics AWAITING PEER REVIEW
Supporting communities of practice – A Journey to effective problem-solving [version 1; peer review: awaiting peer review]
Christina Hanschke, James Baer, Alok Gangaramany, Janneke Verheijen, Nduku Kilonzo, Bryan Okiya, Leonard Kibe Ranji, Stephen Amolo Amolo, Simon Zwane, Rejoice Nkambule, Violet Buluma, Sylvia Ojoo, Susan Kim, Sharon Kibwana, Mark Dybul, Steve Kretschmer
Peer Reviewers Invited
Funder
Bill and Melinda Gates Foundation
PUBLISHED 17 Jul 2020

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 18 July 2020]

Open Letter metrics AWAITING PEER REVIEW
Direct and indirect effects of COVID-19 on perinatal outcomes in low- and middle-income countries [version 1; peer review: awaiting peer review]
Felisita Tupou Ratu, Kathleen Ryan, Netsanet Workneh Gidi, Ilisapeci Vereti, Tsinuel Girma, Jeremy Oats, Ingrid Bucens, Alexandra Robinson, Claire von Mollendorf, Fiona M. Russell
Peer Reviewers Invited
Funder
Bill and Melinda Gates Foundation
PUBLISHED 16 Jul 2020

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 18 July 2020]

Open Letter metrics AWAITING PEER REVIEW
How to engage communities on a large scale? Lessons from World Mosquito Program in Rio de Janeiro, Brazil [version 1; peer review: awaiting peer review]
Guilherme B. Costa, Ruth Smithyman, Scott L. O’Neill, Luciano A. Moreira
Peer Reviewers Invited
Funders
Bill and Melinda Gates Foundation
Ministério da Saúde Brasil
PUBLISHED 17 Jul 2020

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 18 July 2020]

Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
Authors: Long Chiau Ming, Zahid Hussain, Siang Fei Yeoh, David Koh and Kah Seng Lee
Content type: Letter to the Editor
16 July 2020
The World Health Organisation Western Pacific Region countries were declared free of polio in 2000 until a polio outbreak involving 305 cases occurred in Indonesia in 2006. It was not until 2014 that the World Health Organisation South East Asia region was officially declared polio-free again. However, in February 2019, the Global Polio Eradication Initiative announced a new circulating vaccine-derived poliovirus outbreak in the Papua province of Indonesia. To make matter worse, the outbreak responses were tardy and led to transmission among migrating communities to other cities. The pressing regional issues of polio outbreak caused by circulating vaccine-derived poliovirus and use of oral polio vaccine have not been well presented. Our letter highlighted the suboptimal outbreak responses as well as the necessity of cross-border vaccination to curb continued poliovirus transmission.

Health Affairs
Vol. 39, No. 7 July 2020
https://www.healthaffairs.org/toc/hlthaff/current

Food, Income, Work & More
Interview Culture Of Health
Tackling Social Determinants Of Health Around The Globe
Alan R. Weil
Open Access

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 18 July 2020]

Social innovation for health: engaging communities to address infectious diseases
Universal health coverage emphasises the value of the community-based delivery of health services to ensure that underserved populations have access to care. In areas where infectious diseases are endemic, the…
Authors: Phyllis Dako-Gyeke, Uche V. Amazigo, Beatrice Halpaap and Lenore Manderson
Citation: Infectious Diseases of Poverty 2020 9:98
Content type: Commentary
Published on: 18 July 2020

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 18 July 2020]

Estimation of exponential growth rate and basic reproduction number of the coronavirus disease 2019 (COVID-19) in Africa
Since the first case of coronavirus disease 2019 (COVID-19) in Africa was detected on February 14, 2020, the cumulative confirmations reached 15 207 including 831 deaths by April 13, 2020. Africa has been desc…
Authors: Salihu S. Musa, Shi Zhao, Maggie H. Wang, Abdurrazaq G. Habib, Umar T. Mustapha and Daihai He
Citation: Infectious Diseases of Poverty 2020 9:96
Content type: Research Article
Published on: 16 July 2020

International Journal of Infectious Diseases
July 2020 Volume 96, p1-714
https://www.ijidonline.com/issue/S1201-9712(20)X0008-7

Coronavirus (COVID-19) Collection
Coronavirus 2019 and health systems affected by protracted conflict: The case of Syria
Aula Abbara, Diana Rayes, Ola Fahham, Omar Alrashid Alhiraki, Munzer Khalil, Abdulrahman Alomar, Ahmad Tarakji
p192–195
Published online: May 7, 2020

International Journal of Infectious Diseases
July 2020 Volume 96, p1-714
https://www.ijidonline.com/issue/S1201-9712(20)X0008-7

COVID-19 and religious congregations: Implications for spread of novel pathogens
Sayed A. Quadri
p219–221
Published online: May 7, 2020

International Journal of Infectious Diseases
July 2020 Volume 96, p1-714
https://www.ijidonline.com/issue/S1201-9712(20)X0008-7

Mitigating lockdown challenges in response to COVID-19 in Sub-Saharan Africa
Leonard E.G. Mboera, George O. Akipede, Amitava Banerjee, Luis E. Cuevas, Thomas Czypionka, Mishal Khan, Richard Kock, David McCoy, Blandina T. Mmbaga, Gerald Misinzo, Elizabeth H. Shayo, Meru Sheel, Calvin Sindato, Mark Urassa
p308–310
Published online: May 10, 2020

JAMA Network
COVID-19 Update July 18, 2020

These articles on COVID-19 were published across the JAMA Network in the last week.

JAMA
July 14, 2020, Vol 324, No. 2, Pages 121-206
https://jamanetwork.com/journals/jama/currentissue

Viewpoint
Monoclonal Antibodies for Prevention and Treatment of COVID-19
Mary Marovich, MD; John R. Mascola, MD; Myron S. Cohen, MD
free access has multimedia
JAMA. 2020;324(2):131-132. doi:10.1001/jama.2020.10245
This Viewpoint discusses the potential role of neutralizing monoclonal antibodies (MAbs) as a treatment for coronavirus disease 2019 (COVID-19) and as a means of prevention in high-risk populations, and it also raises possible limitations of the approach that need to be disproven or addressed for the strategy to be effective.

JAMA
July 14, 2020, Vol 324, No. 2, Pages 121-206
https://jamanetwork.com/journals/jama/currentissue

COVID-19: Beyond Tomorrow
The Urgency and Challenge of Opening K-12 Schools in the Fall of 2020
Joshua M. Sharfstein, MD; Christopher C. Morphew, PhD
free access has active quiz has multimedia has audio
JAMA. 2020;324(2):133-134. doi:10.1001/jama.2020.10175
This Viewpoint proposes a policy framework for reopening of US primary, middle, and high schools (kindergarten through 12th grade) in fall 2020, including ramping up community public health responses in the summer, symptom screening of students, and privileging return-to-school decisions for younger children and others at risk for education disparities.
Audio Author Interview: Coronavirus Q&A: Opening School in the Fall
Audio Author Interview: The Next COVID-19 Phase

JAMA
July 14, 2020, Vol 324, No. 2, Pages 121-206
https://jamanetwork.com/journals/jama/currentissue

Regulating Medicines in a Globalized World With Increased Recognition and Reliance Among RegulatorsA National Academies Report
Lawrence O. Gostin, JD; Alastair J. Wood, MD; Patricia A. Cuff, MS, MPH
JAMA. 2020;324(2):145-146. doi:10.1001/jama.2019.21793
This Viewpoint summarizes recommendations from a 2020 National Academies of Sciences, Engineering, and Medicine (NASEM) committee report on ways to improve regulatory oversight of drugs in an era of global pharmaceutical research and development.

JAMA
July 14, 2020, Vol 324, No. 2, Pages 121-206
https://jamanetwork.com/journals/jama/currentissue

Sustainability, Business, and Health
George Serafeim, DBA; Amanda M. Rischbieth, PhD; Howard K. Koh, MD, MPH
has audio
JAMA. 2020;324(2):147-148. doi:10.1001/jama.2020.8714
This Viewpoint discusses examples of how many private sector businesses have aligned their core missions with civil and human rights and sustainability reforms, and emphasizes the importance of engaging the sector in achieving public health goals and accelerating worldwide recovery from the COVID-19 pandemic.

Journal of Epidemiology & Community Health
August 2020 – Volume 74 – 8
https://jech.bmj.com/content/74/8

Commentary
Harnessing behavioural science in public health campaigns to maintain ‘social distancing’ in response to the COVID-19 pandemic: key principles (8 May, 2020) Free
Chris Bonell, Susan Michie, Stephen Reicher, Robert West, Laura Bear, Lucy Yardley, Val Curtis, Richard Amlôt, G James Rubin

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 18 July 2020]

Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian’s perspective
Drug repositioning is the scientific strategy of investigating existing drugs for additional clinical indications. The advantages of drug repositioning are that it benefits patients and that it adds new indica…
Authors: A. B. Bayoumy, N. K. H. de Boer, A. R. Ansari, F. Crouwel and C. J. J. Mulder
Citation: Journal of Pharmaceutical Policy and Practice 2020 13:45
Content type: Review
Published on: 17 July 2020

Journal of Travel Medicine
Volume 27, Issue 4, May 2020
https://academic.oup.com/jtm/issue/27/4

Editorial
Successful smallpox eradication: what can we learn to control COVID-19?
D L Heymann, MD, Profeseor, Annelies Wilder-Smith, MD, Professor
Journal of Travel Medicine, Volume 27, Issue 4, May 2020, taaa090, https://doi.org/10.1093/jtm/taaa090
The public health community needs to learn from history and needs to regain its ability to do shoe-leather public health. If we come together collectively and use the public health tools that we have at hand, we will be successful in containing COVID-19 despite geopolitical tensions, just as we were successful in eradicating smallpox despite the Cold War at the time.

Journal of Travel Medicine
Volume 27, Issue 4, May 2020
https://academic.oup.com/jtm/issue/27/4

Original Article
Meningococcal and pneumococcal carriage in Hajj pilgrims: findings of a randomized controlled trial
Al-Mamoon Badahdah, PhD, Marwan A Bakarman, FFCM, Ameneh Khatami, MD, Mohamed Tashani, PhD, Osamah Barasheed, MPH …
Journal of Travel Medicine, Volume 27, Issue 4, May 2020, taaa032, https://doi.org/10.1093/jtm/taaa032

The Lancet
Jul 18, 2020 Volume 396 Number 10245 p143-212, e2-e5
https://www.thelancet.com/journals/lancet/issue/current

Editorial
No more normal
The Lancet

The Lancet
Jul 18, 2020 Volume 396 Number 10245 p143-212, e2-e5
https://www.thelancet.com/journals/lancet/issue/current

Comment
The Lancet–Chatham House Commission on improving population health post COVID-19
Harry Rutter, Richard Horton, Theresa M Marteau

Nature
Volume 583 Issue 7816, 16 July 2020
http://www.nature.com/nature/current_issue.html

Editorial | 14 July 2020
Time to revise the Sustainable Development Goals
The pandemic has set back efforts to achieve the original 2015 targets. The need for change to make them more attainable is stronger than ever.

Nature Medicine
Volume 26 Issue 7, July 2020
https://www.nature.com/nm/volumes/26/issues/7

Comment | 11 June 2020
Socio-demographic and epidemiological consideration of Africa’s COVID-19 response: what is the possible pandemic course?
Africa is said to be the next possible hotspot for COVID-19. However, we believe this is still preventable.
Bamba Gaye, Stéphanie Khoury[…] & Xavier Jouven

Nature Medicine
Volume 26 Issue 7, July 2020
https://www.nature.com/nm/volumes/26/issues/7

Comment | 11 June 2020
COVID-19 in Africa: the spread and response
Given the current trends in incidence and underlying healthcare systems vulnerabilities, Africa could become the next epicenter of the COVID-19 pandemic. As the pandemic transitions to more widespread community transmission, how can the lessons learned thus far be consolidated to effectively curb the spread of COVID-19 while minimizing social disruption and negative humanitarian and economic consequences?
Marguerite Massinga Loembé, Akhona Tshangela[…] & John N. Nkengasong

New England Journal of Medicine
July 16, 2020 Vol. 383 No. 3
http://www.nejm.org/toc/nejm/medical-journal

Perspective
Africa in the Path of Covid-19
Wafaa M. El-Sadr, M.D., M.P.H., M.P.A., and Jessica Justman, M.D.

PLoS Neglected Tropical Diseases
http://www.plosntds.org/
(Accessed 18 July 2020)

Disproportionate impact of the COVID-19 pandemic on immigrant communities in the United States
Eva Clark, Karla Fredricks, Laila Woc-Colburn, Maria Elena Bottazzi, Jill Weatherhead
Viewpoints | published 13 Jul 2020 PLOS Neglected Tropical Diseases
https://doi.org/10.1371/journal.pntd.0008484

PLoS One
http://www.plosone.org/
[Accessed 18 July 2020]

Retraction: Improving measles vaccine uptake rates in Nigeria: An RCT evaluating the impact of incentive sizes and reminder calls on vaccine uptake
Steven Brownstone, Alison Connor, Daniel Stein, the PLOS ONE Editors
Retraction | published 14 Jul 2020 PLOS ONE
https://doi.org/10.1371/journal.pone.0236542

Science
17 July 2020 Vol 369, Issue 6501
http://www.sciencemag.org/current.dtl

Letters
COVID-19 policies: Remember measles
By Debarati Guha-Sapir, Maria Moitinho de Almeida, Mory Keita, Gregg Greenough, Eran Bendavid
Science17 Jul 2020 : 261
Nearly 120 million children in 37 countries are at risk of missing their measlescontaining vaccine (MCV) shots this year, as preventive and public health campaigns take a back seat to policies put in place to contain coronavirus disease 2019 (COVID-19) (¹). In March, the World Health Organization (WHO) issued guidelines indicating that mass vaccination campaigns should be put on hold to maintain physical distancing and minimize COVID-19 transmission (²). The disruption of immunization services, even for short periods, will lead to more susceptible individuals, more communities with less than the 95% MCV coverage needed for herd immunity, and therefore more measles outbreaks globally. A mere 15% decrease in routine measles vaccinations—a plausible result of lockdowns and disruption of health services—could raise the burden of childhood deaths by nearly a quarter of a million in poorer countries (³). Solutions for COVID-19, especially among the global poor, cannot include forgoing vaccinations.

Suspending mass vaccination campaigns is particularly pernicious in countries embroiled in conflict. Malnutrition among children and mothers in these regions is all too common—and increases mortality for those also infected by measles (⁴). In the conflict-affected regions of Ituri and North Kivu in eastern Democratic Republic of the Congo (DRC) alone, COVID-19 precautions are expected to delay measles vaccinations for nearly a million children (¹).

COVID-19 mortality has so far been low in most poorer countries and trivial compared with the immediate risk of mortality due to measles. In the DRC, for example, the total number of deaths due to COVID-19 as of June was 37 (⁵), whereas the 2019 measles outbreak in the conflict region of eastern DRC killed more than 6000 people in a matter of months, mostly children (⁶). In some poor countries, more than 40% of the population is younger than 14 years old (⁷). This demographic group is the least affected by COVID-19 (in terms of symptoms, mortality, and transmission) (⁸) but at serious risk of measles (⁹). In addition, because many people in these countries live in cramped housing with unavoidable crowding, policies to minimize COVID-19 at the expense of measles prevention may not even be effective (¹⁰).

Postponement of measles campaigns prioritizes panic-driven policies for controlling COVID-19 without consideration of these policies’ costs. If children are not immunized within the correct age window, they forgo benefits of lifelong immunity (¹¹). Whole cohorts of children may be left unprotected. We must balance priorities of containing COVID-19 with efforts to control other high-transmission disease threats in poor countries, especially those affected by conflict.

Systematic Reviews
https://systematicreviewsjournal.biomedcentral.com/articles
[Accessed 18 July 2020]

Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol
Over 4.2 million confirmed cases and more than 285,000 deaths, COVID-19 pandemic continues to harm significant number of people worldwide. Several studies have reported the impact of COVID-19 in general popula…
Authors: Binny Thomas, Abdulrouf Pallivalapila, Wessam El Kassem, Asma Tarannum, Fatema Al Hail, Mohammed Rijims, Hussain Parappil, Arabo Ibrahim Bayo, Shamsa Ahmad, Zachariah Nazar, Derek Stewart and Moza Al Hail
Citation: Systematic Reviews 2020 9:161
Content type: Protocol
Published on: 18 July 2020

Vaccine
Volume 38, Issue 32 Pages 4917-5076 (6 July 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/32

Conference info Open access
WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71 vaccines
Dianliang Lei, Elwyn Griffiths, Javier Martin

Vaccine
Volume 38, Issue 32 Pages 4917-5076 (6 July 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/32

Discussion Abstract only
Vaccine handling and administration errors should be addressed to improve vaccine program safety
Lee M. Hampton

Vaccine
Volume 38, Issue 32 Pages 4917-5076 (6 July 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/32

Research article Abstract only
HPV vaccine coverage and acceptability among a national sample of sexual minority women ages 18–45
Paul L. Reiter, Gabriela Bustamante, Annie-Laurie McRee

Vaccine
Volume 38, Issue 32 Pages 4917-5076 (6 July 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/32

Research article Open access
Cost-effectiveness of pneumococcal vaccination for elderly in Sweden
Ellen Wolff, Jann Storsaeter, Åke Örtqvist, Pontus Naucler, … Adam Roth

Vaccine
Volume 38, Issue 32 Pages 4917-5076 (6 July 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/32

Research article Abstract only
Community needs and preferences for community pharmacy immunization services
Noha Al Aloola, Raghad Alsaif, Hiba Alhabib, Abdulaziz Alhossan

Vaccine
Volume 38, Issue 32 Pages 4917-5076 (6 July 2020)
https://www.sciencedirect.com/journal/vaccine/vol/38/issue/32

Research article Open access
Economic evaluation of rotavirus vaccination in children of Bhutan
Pempa, Alia Cynthia G. Luz, Nantasit Luangasanatip, Pritaporn Kingkaew, … Frédéric Debellut

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines
(Accessed 18 July 2020)

Open Access Review
Human Papillomavirus Vaccines: An Updated Review
by Liqin Cheng , Yan Wang and Juan Du
Vaccines 2020, 8(3), 391; https://doi.org/10.3390/vaccines8030391 (registering DOI) – 16 Jul 2020
Abstract
Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past decade, have shown promising results in decreasing HPV infection and related diseases, such as warts and precancerous lesions. In this review, we present the updated information about current HPV vaccines…